Brief: Valeo Pharma Inc Sees Q4 Revenue Up 14 To 18 Percent
15/11/2022 12:07
Nov 15 (Reuters) - Valeo Pharma Inc VPH.TO :
* VALEO PHARMA RAISES Q4 AND FULL YEAR 2022 REVENUE GUIDANCE
* VALEO PHARMA INC SEES Q4 REVENUE C$2022 TO C$13
* VALEO PHARMA INC SEES Q4 REVENUE UP 14 TO 18 PERCENT
Source text for Eikon: ID:nCNWGpryRa
Further company coverage: VPH.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Valeo Pharma
See all newsBrief: Valeo Pharma Says Co Initiates Restructuring Proceedings
Brief: Valeo Pharma Amends Credit Facility With Sagard Healthcare Royalty Partners
Brief: Valeo Pharma Announces Restructuring Of Commercial Field Operations To Support Path To Profitability
Brief: Valeo Pharma Announces Appointment Of Mr. Al Moghaddam To Board Of Directors
Brief: Valeo Pharma Amends Agreement With Novartis Pharmaceuticals Canada